In a historic move, the World Health Organization has launched its inaugural clinical trial for an Ebola vaccine in the Democratic Republic of Congo. This trial aims to assess the efficacy of the Ervebo vaccine against the Bundibugyo virus amid a severe outbreak that has resulted in over 9,700 cases and 4,600 fatalities since May.
RSS News
Times of India
0 thoughts on “Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- Little-known Dutch painting from English manor collection sells for £70,000 against £8,000 estimate
- 'Now is the time': Rubio warns Cuba next after Iran, asks Cubans to join hands
- Meghan Explains Estrangement Move: Duchess cites child-safety fears; abuse-image claims under probe
- Three back-to-back earthquakes hit Vanuatu Islands near Australia; tsunami warning issued
- Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain
